We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
+5.6%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$383M
AUM Growth
-$51.9M
Cap. Flow
-$65M
Cap. Flow %
-16.98%
Top 10 Hldgs %
21.34%
Holding
731
New
218
Increased
59
Reduced
110
Closed
344

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$9.03M
2
AAPL icon
Apple
AAPL
+$8.95M
3
MRNA icon
Moderna
MRNA
+$7.35M
4
GS icon
Goldman Sachs
GS
+$5.62M
5
XYZ
Block Inc
XYZ
+$5.37M

Sector Composition

Rank Sector Weight
1 Technology 18.65%
2 Consumer Discretionary 18.29%
3 Consumer Staples 10.44%
4 Healthcare 10.32%
5 Industrials 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SU icon
276
Suncor Energy
SU
$75.6B
$300K 0.08%
12,500
-37,200
-75% -$853K
DLR icon
277
Digital Realty Trust
DLR
$72.4B
$299K 0.08%
+1,984
New +$300K
FUTU icon
278
Futu Holdings
FUTU
$14.6B
$297K 0.08%
1,658
-15,232
-90% -$2.22M
SLM icon
279
SLM Corp
SLM
$4.78B
$297K 0.08%
+14,200
New +$280K
DFS
280
DELISTED
Discover Financial Services
DFS
$296K 0.08%
2,500
-1,800
-42% -$204K
VIRT icon
281
Virtu Financial
VIRT
$5.12B
$296K 0.08%
10,723
+2,214
+26% +$65.9K
ACHC icon
282
Acadia Healthcare
ACHC
$2.99B
$295K 0.08%
+4,700
New +$295K
OTEX icon
283
Open Text
OTEX
$5.73B
$292K 0.08%
5,739
-3,550
-38% -$172K
KGC icon
284
Kinross Gold
KGC
$28.6B
$291K 0.08%
45,800
+20,200
+79% +$150K
ALNY icon
285
Alnylam Pharmaceuticals
ALNY
$37.2B
$288K 0.08%
+1,700
New +$249K
NLSN
286
DELISTED
Nielsen Holdings plc
NLSN
$286K 0.07%
11,600
-13,600
-54% -$355K
TEL icon
287
TE Connectivity
TEL
$60.2B
$284K 0.07%
+2,100
New +$281K
UHS icon
288
Universal Health Services
UHS
$9.64B
$284K 0.07%
1,941
-849
-30% -$128K
CPB icon
289
Campbell Soup
CPB
$6.67B
$283K 0.07%
+6,214
New +$299K
GD icon
290
General Dynamics
GD
$105B
$282K 0.07%
+1,500
New +$283K
TRI icon
291
Thomson Reuters
TRI
$42.7B
$281K 0.07%
+2,690
New +$270K
BBBY
292
Bed Bath & Beyond
BBBY
$512M
$280K 0.07%
3,335
-9,614
-74% -$699K
HR icon
293
Healthcare Realty
HR
$7.46B
$280K 0.07%
+10,500
New +$297K
SKT icon
294
Tanger
SKT
$4.8B
$280K 0.07%
+14,871
New +$261K
CIVI
295
DELISTED
Civitas Resources
CIVI
$278K 0.07%
+5,897
New +$239K
GME icon
296
GameStop
GME
$9.66B
$278K 0.07%
+5,200
New +$252K
VVV icon
297
Valvoline
VVV
$5.05B
$278K 0.07%
+8,571
New +$267K
PFPT
298
DELISTED
Proofpoint, Inc.
PFPT
$278K 0.07%
+1,600
New +$260K
BWA icon
299
BorgWarner
BWA
$13.1B
$277K 0.07%
+6,475
New +$285K
UPST icon
300
Upstart Holdings
UPST
$2.63B
$275K 0.07%
+2,200
New +$271K

Similar funds

Bayesian Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Bayesian Capital Management held 731 positions worth $383M, down 12% from $435M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Bayesian Capital Management withdrew a net $65M in Q2 2021, closing 344 positions and reducing 110 holdings. Its most notable exit was Microsoft, an estimated $9.03M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, Bayesian Capital Management opened a new position in General Mills worth $11M.

  • Bayesian Capital Management's largest Q2 2021 buy was General Mills: 180,673 shares worth $11M.
  • Bayesian Capital Management added most to Amazon in Q2 2021, an estimated $7.31M increase.
  • Bayesian Capital Management's biggest Q2 2021 reduction was Apple, cutting an estimated $8.95M.
  • Bayesian Capital Management fully exited Microsoft in Q2 2021, selling an estimated $9.03M.
  • Bayesian Capital Management's ten largest holdings make up 21% of its $383M portfolio in Q2 2021.
  • Bayesian Capital Management opened 218 new positions and closed 344 in Q2 2021.
  • Bayesian Capital Management's portfolio value fell 12% quarter-over-quarter to $383M.

Based on Bayesian Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.